The Barnstable Brown Gala, the premier Kentucky Derby Gala, today donated over $1 million from proceeds from its 2018 Gala to the University of Kentucky Barnstable Brown Diabetes Center. Since 2008, the Barnstable Brown family has donated more than $15 million to the center from proceeds from the annual Barnstable Brown Derby Eve Gala held in Louisville, Kentucky, including this year's 30th Gala. The 2018 U.S. News & World Report ranked diabetes care at the Barnstable Brown Diabetes Center 33rd in the nation.

By Kristi Willett

(Aug. 24, 2018)  ̶  The executive committee of University of Kentucky Board of Trustees on Aug. 23 approved a plan for UK HealthCare to expand outpatient care throughout the Bluegrass and increase surgical capacity through a joint venture for Lexington Surgery Center.

The joint venture, with UK HealthCare as the majority partner, is with Surgical Care Affiliates, LLC (SCA), the current majority owner of Lexington Surgery Center and part of health services leader Optum.

By Michael McGill

The Kentucky State Loan Repayment Program (KSLRP) is now accepting applications for 2018-2019.

The KSLRP is a loan repayment assistance program that helps to recruit and retain health care providers in rural and underserved communities across the state. Applicants selected to participate in the competitive program agree to work full time for two years providing primary care services at an eligible site located in a Health Professional Shortage Area. Participants receive tax-free student loan repayment for their service commitment.

On Thursday, September 6, 2018 Isabel Diane Derera successfully defended her disseration and was awarded her doctoral degree. Congratulations Dr. Derera!

Alterations in GABAergic NTS Neuron Function in Association with TLE and SUDEP

Doctoral Committee Members
Dr. Bret Smith
Department of Physiology , Mentor

Dr. Brian P. Delisle
Department of Physiology

Dr. Steve Estus
Department of Physiology

Dr. Meriem Bensalem-Owen
Department of Neuroscience

This year’s Cardiovascular Research Day welcomes four trainee presentations from across several areas of the university. Two blocks of trainee presentations will highlight unique studies into cardiovascular research.

Christopher Azbell, MD, joins University of Kentucky department of Otolaryngology in August of 2018. He just recently completed his Pediatric Otolaryngology fellowship at Children's Hospital of Pittsburgh, UPMC, before arriving here in Lexington. Dr. Azbell earned his medical degree from from the University of Alabama at Birmingham School of Medicine and then went on to complete his residency at University of Louisville. Welcome Dr. Azbell!
Alok Saini, MD, joined the University of Kentucky department of Otolaryngology in August of 2018. He is a fellowship trained rhinologist and skull base surgeon. Dr. Saini earned his medical degree from the University of Tennessee Health Science Center in Memphis, TN before completing his residency at Icahn School of Medicine at Mount Sinai in NYC. He then completed his fellowship from the University of Texas Health Science Center at Houston. Welcome Dr. Saini!
CONGRATULATIONS to all of the following: Dr. Lisa Cassis and colleagues (Drs. Andrew Morris, Wendy Katz, Changcheng Zhou and Kevin Pearson) – NIH Phase III Center of Biomedical Research Excellence (COBRE) Dr. Frederique Yiannikouris – a new NIH R01 Dr. Rina Plattner – renewed her R01, NIH supplement and Lloyd Foundation Dr. Zhenheng Guo – a new R01 and VA Award Dr. Barbara Nikolajczyk – 2 NIH Awards transferred Dr. Jia Luo – a new R21 and a VA Award extended Dr. Analia Loria – an NIH supplement Dr. Ai-Ling Lin – an NIH supplement Dr. Olivier Thibault – an NIH supplement Dr.

By Allison Perry

The University of Kentucky Markey Cancer Center has named a new chief of surgical oncology. Dr. Joseph Kim is board certified in surgical oncology and specializes in the treatment of hepatobiliary and gastrointestinal cancers.

The Phase III Center of Biomedical Research Excellence (COBRE) on Obesity and Cardiovascular Diseases (COCVD) focuses on identification of mechanisms and development of therapies that target obesity as a risk factor for cardiovascular diseases, diabetes, cancer and neurodegenerative diseases (e.g., Alzheimer’s disease). 

In its 11th year and extending into 2023, this center promotes 3 scientific core facilities and supports pilot projects that help us understand why obesity increases disease development.